Company Info
Phone(617) 498-0020
Year Established
2002
Ticker
MRSN
Exchange
NASDAQ
Contacts
Martin Huber, MDPresident & CEO
Timothy B. Lowinger, Ph.D.
CSO & CTO
Alejandra Carvajal
CLO
Brian C. DeSchuytner
COO & CFO
Mohan Bala, PhD
CDO
Company Description
Mersana Therapeutics (formerly Nanopharma Corp) is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.